LUNGevity's educational publications are ideal for helping you, the clinician, educate your patients and their caregivers about their diagnosis and treatment
#Video #Collaboration #AdverseEvents #AdoptiveCellTherapy #ImmuneCheckpointInhibitors #Vaccines #Clinician #Oncologist #PrimaryCarePhysician #2017
IMMUNOTHERAPY - The Path to a Cancer Cure! (for Clinicians) Spanish.mp4
Reedit IMMUNOTHERAPY - The Path to a Cancer Cure! (for Clinicians) Chinese_3.mp4
“The future success of cancer immunotherapy research relies on the contributions of the early career scientists and clinicians of today,” said SITC President and SITC Cancer Immunotherapy Winter School co-organizer Lisa H
At the American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago, IL, held June 2-5, 2018, Fight CRC staff and research advocates engaged with researchers, clinicians, and other organizations in the US and around the world to discuss how to continue moving the needle forward in colorectal cancer research, ultimately to improve treatment options and survivorship care for patients. Click here to read about "ASCO 18: What to Expect in Colorectal Cancer Research" #Biomarkers #ClinicalTrials #ColorectalCancer #JournalArticle #CollaborativePartner #ImmuneCheckpointInhibitors #Clinician #RegisteredNurse #Oncologist #Patient #PatientAdvocate #FightColorectalCancer(FCC)
While many international clinicians were accessing the existing materials, this initiative places region-centric, translated resources into the hands of more clinicians
FIT-Cancer IV was an educational program focused on facilitating the exchange of knowledge between immunologists and clinicians, to enable clinicians to integrate immunotherapies into their treatment strategy for cancer patients
03-08-2018 00:00 - 03-10-2018 23:55 CT Madrid
Weiner, MD - University of Iowa Program Summary To ensure effective translation of monoclonal antibody-based cancer immunotherapies to the clinical arena - either as monotherapies or in combination with other cancer therapies - it is critical that clinicians and scientists are educated on the most current information about engineering monoclonal antibodies, immunomodulatory monoclonal antibodies, tumor-targeting monoclonal antibodies, investigation of monoclonal antibodies as vaccines, and the lessons learned from monoclonal antibody therapy in other diseases
7 attachments
Yang, MD - National Cancer Institute Program Summary The Annual Meeting featured an interactive environment that facilitated productive discourse among clinicians, researchers, students, post-doctoral fellows, and allied health professionals from the US, Europe, Asia and beyond
35 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us